214 Efficacy and safety of switching from adalimumab to sarilumab in an open-label extensionof a phase III monotherapy trial in patients with active rheumatoid arthritis

Authors :: Stefano Fiore
Mark C. Genovese
J. Fay
Eun Bong Lee
Gerd R Burmester
Chih-Chi Hu
Source :: Rheumatology. 57
Publication Year :: 2018
Publisher :: Oxford University Press (OUP), 2018.

Subjects :: medicine.medical_specialty
business.industry
medicine.disease
03 medical and health sciences
Sarilumab
0302 clinical medicine
Rheumatology
030220 oncology & carcinogenesis
Rheumatoid arthritis
Internal medicine
medicine
Adalimumab
Pharmacology (medical)
In patient
Open label
business
030217 neurology & neurosurgery
medicine.drug

Full Text Access

Tools